LeonaBio (LONA) Short-term Investments (2020 - 2026)

LeonaBio (LONA) has 7 years of Short-term Investments data on file, last reported at $34.8 million in Q1 2026.

• Short-term Investments for Q1 2026 came in at $34.8 million, up 240.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $34.8 million (up 240.03% YoY), and the FY2025 annual result was $19.1 million, up 571.66% from the prior year.
• Short-term Investments rose to $34.8 million in Q1 2026 per LONA's latest filing, from $19.1 million in the prior quarter.
• Over five years, Short-term Investments peaked at $157.3 million in Q2 2022 and troughed at $2.8 million in Q4 2024.
• A 5-year average of $56.3 million and a median of $44.3 million in 2024 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2024 and 2025: Short-term Investments tumbled 95.01% in 2024, then jumped 571.66% in 2025.
• A 5-year view of Short-term Investments shows it stood at $104.4 million in 2022, then plunged by 45.55% to $56.8 million in 2023, then plunged by 95.01% to $2.8 million in 2024, then jumped by 571.66% to $19.1 million in 2025, then surged by 82.87% to $34.8 million in 2026.
• Business Quant data shows LONA's Short-term Investments at $34.8 million in Q1 2026, $19.1 million in Q4 2025, and $4.4 million in Q3 2025.